• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Q/C Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    3/13/26 4:30:38 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $QCLS alert in real time by email
    false 0001321834 0001321834 2026-03-09 2026-03-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    Current Report

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): March 9, 2026

     

    Q/C Technologies, Inc.

    (Exact name of Registrant as specified in its charter)

     

    Delaware   001-36268   22-2983783
    (State or other jurisdiction
    of incorporation)
      (Commission
    File No.)
      (IRS Employer
    Identification No.)

     

    1185 Avenue of the Americas, Suite 249    
    New York, NY   10036
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (856) 848-8698

     

     

    (Former name or former address, if changed since last report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities Registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common stock, par value $0.001 per share   QCLS   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 4.01 Changes in Registrant’s Certifying Accountant.

     

    (a) Dismissal of Independent Registered Public Accounting Firm

     

    On March 9, 2026, the Audit Committee of the Board of Directors (the “Committee”) of Q/C Technologies, Inc. (the “Company”) approved the dismissal of Stephano Slack LLC (“Stephano Slack”) as the Company’s independent registered public accounting firm, effective as of the same date.

     

    The reports of Stephano Slack on the Company’s consolidated financial statements for the fiscal years ended December 31, 2024 and December 31, 2023, did not contain an adverse opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except as follows: Stephano Slack’s report on the consolidated financial statements of the Company as of December 31, 2024 and 2023 and for each of the years then ended, contained a separate paragraph stating, “The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the consolidated financial statements, the Company has experienced a net loss and negative cash flows from operations for the year ended December 31, 2024, which raises substantial doubt about their ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 3. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.”

     

    From October 3, 2023, through March 9, 2026, the date of Stephano Slack’s dismissal, there were (a) no disagreements (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) between the Company and Stephano Slack on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of Stephano Slack, would have caused Stephano Slack to make reference to such disagreement in its reports, if such reports had been issued, and (b) no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K and the related instructions).

     

    The Company provided Stephano Slack with a copy of this Current Report on Form 8-K prior to its filing with the U.S. Securities and Exchange Commission (the “SEC”) and requested that Stephano Slack furnish the Company with a letter addressed to the SEC, pursuant to Item 304(a)(3) of Regulation S-K, stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A copy of the letter, dated March 11, 2026, is filed as Exhibit 16.1 (which is incorporated by reference herein) to this Current Report on Form 8-K.

     

    (b) Appointment of New Independent Registered Public Accounting Firm

     

    On March 9, 2026, the Committee engaged Grassi & Co., CPAs, P.C. (“Grassi”) as the Company’s independent registered public accounting firm to audit the Company’s financial statements for the year ended December 31, 2025, effective immediately. During the fiscal years ended December 31, 2025, and December 31, 2024, and the subsequent interim period through March 9, 2026, neither the Company nor anyone on its behalf has consulted with Grassi regarding (i) the application of accounting principles to any specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Grassi concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii) any matter that was either the subject of a “disagreement,” as defined in Item 304(a)(1)(iv) of Regulation S-K, or a “reportable event,” as defined in Item 304(a)(1)(v) of Regulation S-K.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit Number   Description
    16.1   Letter dated March 11, 2026, from Stephano Slack LLC to the U.S. Securities and Exchange Commission.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      Q/C TECHNOLOGIES, INC.
         
    Date: March 13, 2026 By: /s/ Joshua Silverman
      Name: Joshua Silverman
      Title: Executive Chairman

     

     

    Get the next $QCLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QCLS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QCLS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Q/C Technologies Launches Optical Processing Unit (OPU) Initiative to Develop Proprietary Silicon Photonic Computing Architecture for AI Inference

      New initiative aimed at developing optical computing technologies to overcome the performance and energy limitations of traditional electronic architectures New York, NY, March 18, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C" or "the Company"), today announced the launch of a new initiative to design and prototype a proprietary optical processing unit (OPU) aimed at tackling the growing performance and energy constraints in artificial intelligence inference infrastructure. Optical computing overcomes challenges posed by electronic GPUs. Artificial intelligence is dominated by one operation: the matrix multiplication. Photons can be configured to perform matrix m

    3/18/26 9:15:00 AM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

    New York, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company"), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Chelsea Voss to its Board of Directors. Ms. Voss is a computer scientist and Member of Technical Staff at OpenAI, where she has played a key role in the development, evaluation, and launch of some of the most advanced, widely used artificial intelligence systems. Her expertise spans machine learning infrastructure, model evaluation, hardware reliability, and published research contributions including results across image generation, ML interpretability, and reinforcement le

    1/20/26 9:15:00 AM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli

    New York, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C" or "the Company"), a pioneer of quantum-class computing at the speed of light, today announced that Martin Shkreli become a Strategic Advisor to the Company, contributing his experience in technology, industry contacts, financial innovation and early-stage growth. Q/C Technologies welcomes Martin as part of its expanding advisory team alongside James Altucher, further strengthening the Company's depth of expertise across computing, AI, and blockchain technologies. "I'm convinced that the next leap in frontier computing is optical, not purely quantum. Q/C's ‘quantum class' technology approach bridges f

    12/9/25 9:15:00 AM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $QCLS
    SEC Filings

    View All

    SEC Form 10-K filed by Q/C Technologies Inc.

    10-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)

    4/15/26 5:20:18 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form NT 10-K filed by Q/C Technologies Inc.

    NT 10-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)

    3/31/26 4:30:23 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Q/C Technologies Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)

    3/13/26 4:30:38 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $QCLS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by White Billy Joe

    4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)

    4/15/26 6:29:10 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Friscia Stephen

    4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)

    4/15/26 6:29:11 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form 4 filed by Voss Chelsea Sierra

    4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)

    4/15/26 6:29:11 PM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $QCLS
    Leadership Updates

    Live Leadership Updates

    View All

    Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors

    New York, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C Technologies" or "the Company"), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Chelsea Voss to its Board of Directors. Ms. Voss is a computer scientist and Member of Technical Staff at OpenAI, where she has played a key role in the development, evaluation, and launch of some of the most advanced, widely used artificial intelligence systems. Her expertise spans machine learning infrastructure, model evaluation, hardware reliability, and published research contributions including results across image generation, ML interpretability, and reinforcement le

    1/20/26 9:15:00 AM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

    Dr. Frankel brings extensive knowledge and deep expertise that bridges advanced physics and quantum technologies New York, NY, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Q/C Technologies, Inc. (NASDAQ:QCLS) ("Q/C" or the "Company"), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Steven Frankel, Ph.D. as Senior Quantum Advisor. Dr. Frankel will help guide the Company's ongoing efforts in quantum-class photonic computing to advance the development and commercialization of Q/C's innovative Laser Processing Unit (LPU). Developed by LightSolver, Q/C's LPU is the world's first light and laser-based computing system designed to solve complex optimization an

    10/16/25 9:15:00 AM ET
    $QCLS
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care